FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35910011000001105: Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110958101000001115 Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110958201000001110 Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Is a Bendroflumethiazide + Potassium true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Plays role Diuretic therapeutic role true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Is a Product containing bendroflumethiazide and potassium false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has active ingredient Potassium false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bendroflumethiazide 2.5mg / Potassium 7.7mmol modified-release tablets 56 tablet Has VMP True Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Inferred relationship Existential restriction modifier
Centyl K modified-release tablets (LEO Pharma) Is a True Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start